What Is Niacin ER? Uses, Dosing, and Side Effects

Niacin ER is a prescription form of vitamin B3 (niacin) designed to release slowly in your body over several hours. It’s primarily used to improve cholesterol levels, specifically to raise “good” HDL cholesterol and lower triglycerides and “bad” LDL cholesterol. The “ER” stands for extended-release, which distinguishes it from regular immediate-release niacin supplements you can buy over the counter. The slow-release design matters because it dramatically reduces the most notorious side effect of niacin therapy: skin flushing.

How Extended-Release Differs From Regular Niacin

Regular niacin hits your bloodstream quickly, causing a rush of the vitamin that triggers intense flushing, a warm, red, itchy sensation across your face and upper body. Niacin ER delivers the same active ingredient but spreads absorption over a longer window. After taking it, blood levels of niacin peak around 4 to 5 hours later, compared to roughly 30 to 60 minutes with the immediate-release version.

This slower delivery makes a significant practical difference. In clinical comparisons at the same 1,500 mg daily dose, patients taking immediate-release niacin experienced an average of 8.56 flushing episodes over a four-week period. Those on the extended-release version averaged just 1.88 episodes over the same period. About the same proportion of people flushed at least once, but the frequency dropped substantially.

There’s also an important distinction between prescription niacin ER and over-the-counter “sustained-release” niacin supplements. These are not the same product. OTC sustained-release formulations have historically been linked to a higher risk of liver toxicity because of how they’re metabolized. Prescription niacin ER (originally sold as Niaspan) was specifically engineered to balance flushing reduction with liver safety, and its release profile falls between immediate-release and sustained-release forms.

What Niacin ER Does to Cholesterol

Niacin ER affects all three major lipid markers, which makes it unusual among cholesterol medications. At therapeutic doses, it can lower LDL cholesterol by 10 to 25 percent, reduce triglycerides by 20 to 50 percent, and raise HDL cholesterol by 15 to 35 percent. That HDL-raising ability is particularly notable because very few medications move HDL meaningfully.

Your body processes niacin through two main pathways. One converts it into a compound that gets filtered out through urine. The other feeds it into the production of a coenzyme (NAD) that plays a central role in energy metabolism. At the high doses used for cholesterol management, both of these pathways get overwhelmed, which is part of why side effects occur and why gradual dose increases are important.

Typical Dosing Schedule

Niacin ER follows a slow titration to minimize side effects. Treatment starts at 500 mg taken once daily at bedtime. The dose increases by no more than 500 mg every four weeks, giving your body time to adjust. Most people end up on 1,000 to 2,000 mg per day, and doses above 2,000 mg daily are not recommended.

Bedtime dosing with a low-fat snack is standard. Taking it with food reduces stomach upset, and the overnight timing means most flushing happens while you’re asleep. If you skip doses for an extended period, you typically need to restart at the 500 mg level and titrate up again rather than jumping back to your previous dose.

Managing Flushing and Other Side Effects

Flushing is the most common reason people stop taking niacin ER. It feels like a sunburn-like warmth and redness, usually across the face, neck, and chest, sometimes with itching or tingling. It tends to be worst during the first few weeks and at each dose increase, then fades as your body adapts.

Taking aspirin or ibuprofen about 30 minutes before your niacin ER dose can significantly reduce flushing. Avoiding alcohol and hot beverages around the time you take it also helps, since both dilate blood vessels and make flushing worse. The low-fat snack recommendation isn’t arbitrary either: a high-fat meal can actually increase absorption and intensify side effects.

Beyond flushing, niacin ER can cause stomach discomfort, headache, and in some cases elevations in blood sugar, uric acid, or liver enzymes. People with diabetes may notice their blood sugar becomes harder to control. Those with a history of gout can experience flare-ups because niacin raises uric acid levels. Regular blood work to check liver function and blood sugar is a standard part of niacin ER therapy.

Where Niacin ER Stands Today

Niacin ER’s role in treatment has shifted considerably over the past decade. While it reliably improves cholesterol numbers on paper, two large clinical trials tested whether adding niacin to statin therapy actually prevented heart attacks and strokes. The results were disappointing. In the HPS2-THRIVE trial, which followed over 25,000 high-risk patients for nearly four years, the group taking niacin experienced major cardiovascular events (heart attack, stroke, cardiovascular death, or need for a procedure to open blocked arteries) at essentially the same rate as the placebo group: 13.2% versus 13.7%, a difference that was not statistically meaningful.

The AIM-HIGH trial reached a similar conclusion and was stopped early because niacin showed no benefit over a statin alone. These findings don’t mean niacin ER is useless, but they moved it from a first-line cholesterol treatment to a more limited role. It’s now generally reserved for people who can’t tolerate statins, who have persistently low HDL or high triglycerides despite other treatments, or in specific situations where a prescriber sees potential benefit beyond what statins provide alone.

If you’ve been prescribed niacin ER or are seeing it listed among your medications, the core takeaway is that it’s a pharmaceutical-grade, controlled-release form of vitamin B3 designed for cholesterol management. It is not interchangeable with niacin supplements from a health food store, and switching between formulations without medical guidance can lead to either reduced effectiveness or increased risk of liver problems.